(See the Editorial Commentary by Capeau, on pages 1127–9 .) Background. Human
immunodeficiency virus (HIV)–infected patients may have a greater risk of noninfectious …

Background No therapy is approved for COVID-19 pneumonia. The aim of this study was to
assess the role of tocilizumab in reducing the risk of invasive mechanical ventilation and …

Background Metabolic diseases are frequently observed in HIV‐infected persons and, as the
risk of contracting these diseases is age‐related, their prevalence will increase in the future …

The immune system of patients infected by SARS-CoV-2 is severely impaired. Detailed
investigation of T cells and cytokine production in patients affected by COVID-19 pneumonia are …

Background and Aim: The magnitude of the risk of incident type 2 diabetes (T2D) and metabolic
syndrome (MetS) among patients with nonalcoholic fatty liver disease (NAFLD) is poorly …

Background The COVID-19 pandemic has placed unprecedented strain on health-care
systems. Frailty is being used in clinical decision making for patients with COVID-19, yet the …

Weeks and months after the onset of acute COVID-19, people continue to suffer. Paul Garner,
a professor of epidemiology at Liverpool School of Tropical Medicine, UK, wrote on the …

Introduction The severe acute respiratory syndrome-coronavirus 2 outbreak spread rapidly
in Italy and the lack of intensive care unit (ICU) beds soon became evident, forcing the …

Background Hospital admissions for non-coronavirus disease 2019 (COVID-19) pathology
have decreased significantly. It is believed that this may be due to public anxiety about …

Background. The prevalence and predictors of nonalcoholic fatty liver disease (NAFLD) in
human immunodeficiency virus (HIV)-infected highly active antiretroviral therapy-experienced …